Your browser doesn't support javascript.
loading
Routine blood monitoring in maintenance immunoglobulin treatment of inflammatory neuropathy: Is it clinically relevant?
Keh, R; Kahlil, A; Nihoyannopoulos, L; Compton, L; Kapoor, M; Gosal, D; Manji, H; Rossor, A M; Reilly, M M; Lunn, M P; Lavin, T M; Carr, A S.
Afiliação
  • Keh R; Manchester Centre for Clinical Neuroscience, Salford Royal Hospital, Salford, UK.
  • Kahlil A; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Nihoyannopoulos L; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Compton L; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Kapoor M; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Gosal D; Manchester Centre for Clinical Neuroscience, Salford Royal Hospital, Salford, UK.
  • Manji H; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Rossor AM; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Reilly MM; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK; MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Lunn MP; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK.
  • Lavin TM; Manchester Centre for Clinical Neuroscience, Salford Royal Hospital, Salford, UK.
  • Carr AS; Centre for Neuromuscular Diseases, 8-11 Queens Square, National Hospital of Neurology and Neurosurgery, London, UK. Electronic address: Aisling.carr@nhs.net.
J Neurol Sci ; 408: 116527, 2020 Jan 15.
Article em En | MEDLINE | ID: mdl-31677558
BACKGROUND: Pre-treatment screening for IgA deficiency and close monitoring of full blood count(FBC) and renal function is recommended with intravenous immunoglobulin(IVIg) therapy in neurological diseases. AIMS: To examine the frequency of biochemically defined and clinically significant episodes of treatment associated haemolysis, neutropenia, thrombocytopenia and acute kidney injury(AKI) in a cohort of patients on maintenance Immunoglobulin(Ig) therapy for inflammatory neuropathy. METHODS: A retrospective review of routine blood monitoring in patients from two UK specialist peripheral nerve centres. Accepted definitions for clinically and biochemically significant haemolysis, neutropenia, thrombocytopenia and AKI were used. RESULTS: 1919 infusion episodes in 90 patients were analysed. Age(mean(S.D)) = 58.09(14.4)years, 63% male, 72% CIDP(28% MMN), 97% IVIg(3% SCIg). Dose = 1.57(0.79)g/kg/month or 97.1(37.3)g/infusion, frequency:3.9(1.4) weeks. Relative IgA deficiency was noted in 2 individuals (prevalence:2.2%, 95%C.I.:0-5.2) who received a combined total of 38 infusions(3800 g IVIg) without adverse event. No clinically significant episodes of haemolysis, neutropenia, thrombocytopenia or AKI occurred in relation to treatment. An asymptomatic drop>10 g/L haemoglobin(Hb) occurred in 3.5%(95%CI:2.7-4.3) of treatment episodes in 38 individuals, mean reduction:17.7(7.4)g/L; lowest Hb:86 g/L. Lower pre-treatment haemoglobin correlated with risk of recurrent Ig-related drop(p:0.007). Two patients with chronic renal failure(stage 1 and 3) received 28(IV) and 104(SC) infusions respectively(6416 g) without impact on estimated glomerular filtration rate(eGFR). CONCLUSIONS: No clinically significant Ig-related episodes of haemolysis or AKI were identified in this representative cohort. This suggests that routine monitoring is not essential in long-term Ig use but should be considered when clinically indicated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Monitoramento de Medicamentos / Polirradiculoneuropatia Desmielinizante Inflamatória Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Sci Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas Intravenosas / Monitoramento de Medicamentos / Polirradiculoneuropatia Desmielinizante Inflamatória Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurol Sci Ano de publicação: 2020 Tipo de documento: Article